SOPHiA GENETICS SA
SOPH- Exchange
- Nasdaq
- Industry
- Services-Computer Processing & Data Preparation
- SEC CIK
- 0001840706
In the last 90 days, SOPHiA GENETICS SA insiders filed 0 open-market purchases and 35 sales; 71 institutions reported holding it in 13F filings for Q2 2026, worth $212.5M in total; Akre Capital Management is the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding SOPHiA GENETICS SA changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 32 | 1 | 31 | 0 |
| Shares | 17.5M | 2.17M | 17.9M | +2.58M (+16.8%) |
| Value | $86.3M | $10.7M | $82.1M | +$6.45M (+8.5%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held SOPHiA GENETICS SA at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Asset Management Americas Inc | 2,222,347 | $10.2M | 0.00% |
| Tower Research Capital LLC (TRC) | 35 | $160 | 0.00% |
| Citigroup Inc | 15 | $69 | 0.00% |
Sold out (3)
Institutions that held SOPHiA GENETICS SA at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Parkman Healthcare Partners LLC | 209,896 | $1.03M |
| Schonfeld Strategic Advisors LLC | 61,200 | $301.7K |
| Nordwand Advisors, LLC | 500 | $2.46K |
Not filed for Q2 2024 yet (1)
Institutions that held SOPHiA GENETICS SA at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 2,167,540 | $10.7M |